Cravath’s London Office Moves to 100 Cheapside
Ryan J. Wichtowski advises the Firm’s clients on a broad range of complex intellectual property issues, including those that arise in the context of corporate and financing transactions. His transactional experience includes counseling clients on mergers and acquisitions, spin‑offs and separations, complex licensing arrangements, partnerships, joint ventures and collaborations.
Mr. Wichtowski’s notable matters include representing:
- Disney in its $85 billion acquisition of 21st Century Fox, the $3.47 billion sale of its interest in the YES Network to an investor group including the Yankees and Sinclair, the combination of its Hulu + Live TV business with Fubo and ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports;
- Axalta in its pending $25 billion merger of equals with AkzoNobel;
- Thermo Fisher Scientific in its $20.9 billion acquisition of PPD;
- Johnson & Johnson in its $16.6 billion acquisition of Abiomed and its $6.5 billion acquisition of Momenta;
- Forward Air in its combination with Omni Logistics, creating a $3.7 billion company;
- Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
- Brookfield Renewable in its $2.8 billion acquisition of Duke Energy Renewables;
- Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
- Vista Outdoor in the $2.225 billion sale of The Kinetic Group to Czechoslovak Group and the $1.125 billion sale of Revelyst to SVP;
- Cowen in its $1.9 billion acquisition by TD;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
- altafiber in the $670 million sale of CBTS to TowerBrook;
- Tabula Rasa in its $570 million take‑private acquisition by Nautic;
- WiseTech Global in its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
- OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
- INEOS in its $404 million acquisition of a 50% membership interest in Gemini HDPE from Sasol;
- Biogen in the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments;
- Cable One in the formation of Clearwave Fiber, a joint venture with GTCR, Stephens Capital Partners and The Pritzker Organization;
- CardWorks in its acquisition of Ally’s credit card business;
- Future Standard in its acquisition of the Digital Infrastructure platform of Post Road Group;
- IBM in connection with the launch by Technip Energies of Reju, a company that will leverage technology IBM co‑developed in a joint venture with Under Armour and Technip Energies;
- RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
- RELX in its acquisition of Shadow Health; and
- Viatris in its global research and development collaboration with Idorsia Pharmaceuticals.
Mr. Wichtowski has also advised on intellectual property litigation matters, including securing victories for Alarm.com in patent infringement litigation brought by Vivint and securing a settlement for Biogen relating to litigation concerning its introduction of a biosimilar to Genentech’s rheumatoid arthritis drug.
Mr. Wichtowski is a registered patent attorney and a member of the New York Intellectual Property Law Association (NYIPLA).
Mr. Wichtowski comes from Deep River, Connecticut. He received a B.S. summa cum laude from Fordham University in 2015 and a J.D. cum laude from Duke Law School in 2018, where he was an editor of the Law Journal and a staff editor of the Law & Technology Review.
Mr. Wichtowski joined Cravath in 2018 and was elected a partner in 2025.
Mr. Wichtowski’s notable matters include representing:
- Disney in its $85 billion acquisition of 21st Century Fox, the $3.47 billion sale of its interest in the YES Network to an investor group including the Yankees and Sinclair, the combination of its Hulu + Live TV business with Fubo and ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports;
- Axalta in its pending $25 billion merger of equals with AkzoNobel;
- Thermo Fisher Scientific in its $20.9 billion acquisition of PPD;
- Johnson & Johnson in its $16.6 billion acquisition of Abiomed and its $6.5 billion acquisition of Momenta;
- Forward Air in its combination with Omni Logistics, creating a $3.7 billion company;
- Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
- Brookfield Renewable in its $2.8 billion acquisition of Duke Energy Renewables;
- Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
- Vista Outdoor in the $2.225 billion sale of The Kinetic Group to Czechoslovak Group and the $1.125 billion sale of Revelyst to SVP;
- Cowen in its $1.9 billion acquisition by TD;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
- altafiber in the $670 million sale of CBTS to TowerBrook;
- Tabula Rasa in its $570 million take‑private acquisition by Nautic;
- WiseTech Global in its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
- OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
- INEOS in its $404 million acquisition of a 50% membership interest in Gemini HDPE from Sasol;
- Biogen in the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments;
- Cable One in the formation of Clearwave Fiber, a joint venture with GTCR, Stephens Capital Partners and The Pritzker Organization;
- CardWorks in its acquisition of Ally’s credit card business;
- Future Standard in its acquisition of the Digital Infrastructure platform of Post Road Group;
- IBM in connection with the launch by Technip Energies of Reju, a company that will leverage technology IBM co‑developed in a joint venture with Under Armour and Technip Energies;
- RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
- RELX in its acquisition of Shadow Health; and
- Viatris in its global research and development collaboration with Idorsia Pharmaceuticals.
Mr. Wichtowski has also advised on intellectual property litigation matters, including securing victories for Alarm.com in patent infringement litigation brought by Vivint and securing a settlement for Biogen relating to litigation concerning its introduction of a biosimilar to Genentech’s rheumatoid arthritis drug.
Mr. Wichtowski is a registered patent attorney and a member of the New York Intellectual Property Law Association (NYIPLA).
Mr. Wichtowski comes from Deep River, Connecticut. He received a B.S. summa cum laude from Fordham University in 2015 and a J.D. cum laude from Duke Law School in 2018, where he was an editor of the Law Journal and a staff editor of the Law & Technology Review.
Mr. Wichtowski joined Cravath in 2018 and was elected a partner in 2025.
Education
-
J.D., 2018, Duke Law Schoolcum laude
-
B.S., 2015, Fordham Universitysumma cum laude
Admitted In
- New York
Ryan J. Wichtowski advises the Firm’s clients on a broad range of complex intellectual property issues, including those that arise in the context of corporate and financing transactions. His transactional experience includes counseling clients on mergers and acquisitions, spin‑offs and separations, complex licensing arrangements, partnerships, joint ventures and collaborations.
Mr. Wichtowski’s notable matters include representing:
- Disney in its $85 billion acquisition of 21st Century Fox, the $3.47 billion sale of its interest in the YES Network to an investor group including the Yankees and Sinclair, the combination of its Hulu + Live TV business with Fubo and ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports;
- Axalta in its pending $25 billion merger of equals with AkzoNobel;
- Thermo Fisher Scientific in its $20.9 billion acquisition of PPD;
- Johnson & Johnson in its $16.6 billion acquisition of Abiomed and its $6.5 billion acquisition of Momenta;
- Forward Air in its combination with Omni Logistics, creating a $3.7 billion company;
- Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
- Brookfield Renewable in its $2.8 billion acquisition of Duke Energy Renewables;
- Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
- Vista Outdoor in the $2.225 billion sale of The Kinetic Group to Czechoslovak Group and the $1.125 billion sale of Revelyst to SVP;
- Cowen in its $1.9 billion acquisition by TD;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
- altafiber in the $670 million sale of CBTS to TowerBrook;
- Tabula Rasa in its $570 million take‑private acquisition by Nautic;
- WiseTech Global in its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
- OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
- INEOS in its $404 million acquisition of a 50% membership interest in Gemini HDPE from Sasol;
- Biogen in the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments;
- Cable One in the formation of Clearwave Fiber, a joint venture with GTCR, Stephens Capital Partners and The Pritzker Organization;
- CardWorks in its acquisition of Ally’s credit card business;
- Future Standard in its acquisition of the Digital Infrastructure platform of Post Road Group;
- IBM in connection with the launch by Technip Energies of Reju, a company that will leverage technology IBM co‑developed in a joint venture with Under Armour and Technip Energies;
- RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
- RELX in its acquisition of Shadow Health; and
- Viatris in its global research and development collaboration with Idorsia Pharmaceuticals.
Mr. Wichtowski has also advised on intellectual property litigation matters, including securing victories for Alarm.com in patent infringement litigation brought by Vivint and securing a settlement for Biogen relating to litigation concerning its introduction of a biosimilar to Genentech’s rheumatoid arthritis drug.
Mr. Wichtowski is a registered patent attorney and a member of the New York Intellectual Property Law Association (NYIPLA).
Mr. Wichtowski comes from Deep River, Connecticut. He received a B.S. summa cum laude from Fordham University in 2015 and a J.D. cum laude from Duke Law School in 2018, where he was an editor of the Law Journal and a staff editor of the Law & Technology Review.
Mr. Wichtowski joined Cravath in 2018 and was elected a partner in 2025.
Mr. Wichtowski’s notable matters include representing:
- Disney in its $85 billion acquisition of 21st Century Fox, the $3.47 billion sale of its interest in the YES Network to an investor group including the Yankees and Sinclair, the combination of its Hulu + Live TV business with Fubo and ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports;
- Axalta in its pending $25 billion merger of equals with AkzoNobel;
- Thermo Fisher Scientific in its $20.9 billion acquisition of PPD;
- Johnson & Johnson in its $16.6 billion acquisition of Abiomed and its $6.5 billion acquisition of Momenta;
- Forward Air in its combination with Omni Logistics, creating a $3.7 billion company;
- Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
- Brookfield Renewable in its $2.8 billion acquisition of Duke Energy Renewables;
- Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
- Vista Outdoor in the $2.225 billion sale of The Kinetic Group to Czechoslovak Group and the $1.125 billion sale of Revelyst to SVP;
- Cowen in its $1.9 billion acquisition by TD;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
- altafiber in the $670 million sale of CBTS to TowerBrook;
- Tabula Rasa in its $570 million take‑private acquisition by Nautic;
- WiseTech Global in its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
- OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
- INEOS in its $404 million acquisition of a 50% membership interest in Gemini HDPE from Sasol;
- Biogen in the expansion of its existing agreement with Eisai to jointly develop and commercialize investigational Alzheimer’s disease treatments;
- Cable One in the formation of Clearwave Fiber, a joint venture with GTCR, Stephens Capital Partners and The Pritzker Organization;
- CardWorks in its acquisition of Ally’s credit card business;
- Future Standard in its acquisition of the Digital Infrastructure platform of Post Road Group;
- IBM in connection with the launch by Technip Energies of Reju, a company that will leverage technology IBM co‑developed in a joint venture with Under Armour and Technip Energies;
- RedHill Biopharma in its acquisition of Movantik from AstraZeneca and in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
- RELX in its acquisition of Shadow Health; and
- Viatris in its global research and development collaboration with Idorsia Pharmaceuticals.
Mr. Wichtowski has also advised on intellectual property litigation matters, including securing victories for Alarm.com in patent infringement litigation brought by Vivint and securing a settlement for Biogen relating to litigation concerning its introduction of a biosimilar to Genentech’s rheumatoid arthritis drug.
Mr. Wichtowski is a registered patent attorney and a member of the New York Intellectual Property Law Association (NYIPLA).
Mr. Wichtowski comes from Deep River, Connecticut. He received a B.S. summa cum laude from Fordham University in 2015 and a J.D. cum laude from Duke Law School in 2018, where he was an editor of the Law Journal and a staff editor of the Law & Technology Review.
Mr. Wichtowski joined Cravath in 2018 and was elected a partner in 2025.
Education
-
J.D., 2018, Duke Law Schoolcum laude
-
B.S., 2015, Fordham Universitysumma cum laude
Admitted In
- New York
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.